Ptc Therapeutics (PTCT) Assets Average (2013 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Assets Average of $3.1 billion for Q2 2026, up 15.69% year-over-year from $2.6 billion in Q2 2025, and up 6.1% quarter-over-quarter from $2.9 billion in Q1 2026.
Ptc Therapeutics (PTCT) Assets Average (2013 - 2026) Analysis & Trends
Ptc Therapeutics' Assets Average history runs 14 years deep, the most recent figure standing at $3.1 billion for Q2 2026.
- In Q2 2026, Assets Average rose 15.69% year-over-year to $3.1 billion; the TTM figure through Jun 2026 stood at $3.1 billion (up 15.69% YoY), while the FY2025 annual figure was $2.3 billion, up 27.86% from the prior year.
- Assets Average for Q2 2026 stood at $3.1 billion, up from $2.9 billion in the prior quarter.
- The five-year high for Assets Average was $3.1 billion in Q2 2026, with the low at $1.3 billion in Q3 2023.
- The 5-year median for Assets Average is $1.8 billion (2024), against an average of $2.0 billion.
- The sharpest annual moves came in 2023 and 2025: Assets Average fell 23.15% in 2023, then soared 56.25% in 2025.
- Ptc Therapeutics' Assets Average stood at $1.6 billion in 2022, then fell by 3.85% to $1.6 billion in 2023, then increased by 12.41% to $1.8 billion in 2024, then jumped by 56.25% to $2.8 billion in 2025, then grew by 10.41% to $3.1 billion in 2026.
- Business Quant data shows PTCT's Assets Average at $3.1 billion in Q2 2026, $2.9 billion in Q1 2026, and $2.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 3.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Bn |
| Mar 31, 2026 | 2.88 Bn |
| Dec 31, 2025 | 2.77 Bn |
| Sep 30, 2025 | 2.64 Bn |
| Jun 30, 2025 | 2.64 Bn |
| Mar 31, 2025 | 2.18 Bn |
| Dec 31, 2024 | 1.77 Bn |
| Sep 30, 2024 | 1.88 Bn |
| Jun 30, 2024 | 1.85 Bn |
| Mar 31, 2024 | 1.84 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.47 Bn |
| Mar 31, 2023 | 1.66 Bn |
| Dec 31, 2022 | 1.64 Bn |
| Sep 30, 2022 | 1.69 Bn |
| Jun 30, 2022 | 1.80 Bn |
| Mar 31, 2022 | 1.87 Bn |
| Dec 31, 2021 | 1.97 Bn |
| Sep 30, 2021 | 2.03 Bn |